Bristol Myers Squibb (BMY) Cash from Financing Activities (2009 - 2026)
Bristol Myers Squibb (BMY) reported Cash from Financing Activities of -$1.6 billion for Q1 2026, down 57.1% year-over-year from -$3.6 billion in Q1 2025, and up 74.13% on a QoQ basis from -$6.0 billion in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of Cash from Financing Activities data on file, last reported at -$1.6 billion in Q1 2026.
- Quarterly Cash from Financing Activities fell 57.1% year-over-year to -$1.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.9 billion (down 3.85% YoY) and the FY2025 annual result came in at -$10.3 billion, down 301.83% from the prior year.
- Cash from Financing Activities rose to -$1.6 billion in Q1 2026 per BMY's latest filing, from -$6.0 billion in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $14.6 billion in Q1 2024 and bottomed at -$6.0 billion in Q4 2025.
- The 5-year median for Cash from Financing Activities is -$3.1 billion (2023), against an average of -$2.0 billion.
- Peak annual rise in Cash from Financing Activities reached 580.13% in 2024, while the deepest fall reached 269.8% in 2024.
- Tracing BMY's Cash from Financing Activities over 5 years: stood at -$3.2 billion in 2022, then surged by 129.79% to $967.0 million in 2023, then tumbled by 269.8% to -$1.6 billion in 2024, then plunged by 267.17% to -$6.0 billion in 2025, then surged by 74.13% to -$1.6 billion in 2026.
- Per Business Quant, the three latest BMY Cash from Financing Activities figures stand at -$1.6 billion (Q1 2026), -$6.0 billion (Q4 2025), and -$1.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -3.47 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 530.00 Mn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 919.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -2.98 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 1.44 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | -4.24 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -2.86 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -1.56 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.56 Bn |
| Mar 31, 2026 | -1.56 Bn |
| Dec 31, 2025 | -6.03 Bn |
| Dec 31, 2025 | -6.03 Bn |
| Sep 30, 2025 | -1.49 Bn |
| Sep 30, 2025 | -1.49 Bn |
| Jun 30, 2025 | -1.84 Bn |
| Jun 30, 2025 | -1.84 Bn |
| Mar 31, 2025 | -993.00 Mn |
| Mar 31, 2025 | -993.00 Mn |
| Dec 31, 2024 | -1.64 Bn |
| Dec 31, 2024 | -1.64 Bn |
| Sep 30, 2024 | -3.85 Bn |
| Sep 30, 2024 | -3.85 Bn |
| Jun 30, 2024 | -4.02 Bn |
| Jun 30, 2024 | -4.02 Bn |
| Mar 31, 2024 | 14.64 Bn |
| Mar 31, 2024 | 14.64 Bn |
| Dec 31, 2023 | 967.00 Mn |
| Dec 31, 2023 | 967.00 Mn |
| Sep 30, 2023 | -5.16 Bn |
| Sep 30, 2023 | -5.16 Bn |
| Jun 30, 2023 | -2.17 Bn |
| Jun 30, 2023 | -2.17 Bn |
| Mar 31, 2023 | -3.05 Bn |
| Mar 31, 2023 | -3.05 Bn |
| Dec 31, 2022 | -3.25 Bn |
| Dec 31, 2022 | -3.25 Bn |
| Sep 30, 2022 | -4.54 Bn |
| Sep 30, 2022 | -4.54 Bn |
| Jun 30, 2022 | -3.52 Bn |
| Jun 30, 2022 | -3.52 Bn |
| Mar 31, 2022 | -5.65 Bn |
| Mar 31, 2022 | -5.65 Bn |
| Dec 31, 2021 | -3.97 Bn |
| Dec 31, 2021 | -3.97 Bn |
| Sep 30, 2021 | -1.78 Bn |
| Sep 30, 2021 | -1.78 Bn |
| Jun 30, 2021 | -3.18 Bn |
| Jun 30, 2021 | -3.18 Bn |
| Mar 31, 2021 | -7.30 Bn |
| Mar 31, 2021 | -7.30 Bn |
| Dec 31, 2020 | 3.48 Bn |
| Dec 31, 2020 | 3.48 Bn |
| Sep 30, 2020 | -2.59 Bn |
| Sep 30, 2020 | -2.59 Bn |
| Jun 30, 2020 | -993.00 Mn |
| Jun 30, 2020 | -993.00 Mn |
| Mar 31, 2020 | -1.05 Bn |
| Mar 31, 2020 | -1.05 Bn |
| Dec 31, 2019 | -7.68 Bn |
| Dec 31, 2019 | -7.68 Bn |
| Sep 30, 2019 | -941.00 Mn |
| Sep 30, 2019 | -941.00 Mn |
| Jun 30, 2019 | 18.27 Bn |
| Jun 30, 2019 | 18.27 Bn |
| Mar 31, 2019 | -2.03 Bn |
| Mar 31, 2019 | -2.03 Bn |
| Dec 31, 2018 | -578.00 Mn |
| Dec 31, 2018 | -578.00 Mn |
| Sep 30, 2018 | -720.00 Mn |
| Sep 30, 2018 | -720.00 Mn |
| Jun 30, 2018 | -1.02 Bn |
| Jun 30, 2018 | -1.02 Bn |
| Mar 31, 2018 | -1.22 Bn |
| Mar 31, 2018 | -1.22 Bn |
| Dec 31, 2017 | -1.35 Bn |
| Dec 31, 2017 | -1.35 Bn |
| Sep 30, 2017 | -706.00 Mn |
| Sep 30, 2017 | -706.00 Mn |
| Jun 30, 2017 | -1.01 Bn |
| Jun 30, 2017 | -1.01 Bn |
| Mar 31, 2017 | -1.01 Bn |
| Mar 31, 2017 | -1.01 Bn |
| Dec 31, 2016 | -605.00 Mn |
| Dec 31, 2016 | -605.00 Mn |
| Sep 30, 2016 | -546.00 Mn |
| Sep 30, 2016 | -546.00 Mn |
| Jun 30, 2016 | -552.00 Mn |
| Jun 30, 2016 | -552.00 Mn |
| Mar 31, 2016 | -950.00 Mn |
| Mar 31, 2016 | -950.00 Mn |
| Dec 31, 2015 | -1.36 Bn |
| Dec 31, 2015 | -1.36 Bn |
| Sep 30, 2015 | -700.00 Mn |
| Sep 30, 2015 | -700.00 Mn |
| Jun 30, 2015 | -883.00 Mn |
| Jun 30, 2015 | -883.00 Mn |
| Mar 31, 2015 | -682.00 Mn |
| Mar 31, 2015 | -682.00 Mn |
| Dec 31, 2014 | -231.00 Mn |
| Dec 31, 2014 | -231.00 Mn |
| Sep 30, 2014 | -528.00 Mn |
| Sep 30, 2014 | -528.00 Mn |
| Jun 30, 2014 | -486.00 Mn |
| Jun 30, 2014 | -486.00 Mn |
| Mar 31, 2014 | -1.19 Bn |
| Mar 31, 2014 | -1.19 Bn |
| Dec 31, 2013 | 711.00 Mn |
| Dec 31, 2013 | 711.00 Mn |
| Sep 30, 2013 | -620.00 Mn |
| Sep 30, 2013 | -620.00 Mn |
| Jun 30, 2013 | -1.12 Bn |
| Jun 30, 2013 | -1.12 Bn |
| Mar 31, 2013 | -44.00 Mn |
| Mar 31, 2013 | -44.00 Mn |
| Dec 31, 2012 | -958.00 Mn |
| Dec 31, 2012 | -958.00 Mn |
| Sep 30, 2012 | -1.69 Bn |
| Sep 30, 2012 | -1.69 Bn |
| Jun 30, 2012 | -850.00 Mn |
| Jun 30, 2012 | -850.00 Mn |
| Mar 31, 2012 | -836.00 Mn |
| Mar 31, 2012 | -836.00 Mn |
| Dec 31, 2011 | -754.00 Mn |
| Dec 31, 2011 | -754.00 Mn |
| Sep 30, 2011 | -704.00 Mn |
| Sep 30, 2011 | -704.00 Mn |
| Jun 30, 2011 | -507.00 Mn |
| Jun 30, 2011 | -507.00 Mn |
| Mar 31, 2011 | -692.00 Mn |
| Mar 31, 2011 | -692.00 Mn |
| Dec 31, 2010 | -1.66 Bn |
| Dec 31, 2010 | -1.66 Bn |
| Sep 30, 2010 | -698.00 Mn |
| Sep 30, 2010 | -698.00 Mn |
| Jun 30, 2010 | -495.00 Mn |
| Jun 30, 2010 | -495.00 Mn |
| Mar 31, 2010 | -486.00 Mn |
| Mar 31, 2010 | -486.00 Mn |
| Dec 31, 2009 | 994.00 Mn |
| Dec 31, 2009 | 994.00 Mn |
| Sep 30, 2009 | -656.00 Mn |
| Sep 30, 2009 | -656.00 Mn |